USD 2.02
(-8.18%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 60.82 Million USD | 456.61% |
2022 | 10.92 Million USD | -36.03% |
2021 | 17.08 Million USD | 3.28% |
2020 | 16.53 Million CAD | 28.43% |
2019 | 12.87 Million CAD | 45.43% |
2018 | 8.85 Million CAD | 18.65% |
2017 | 7.46 Million CAD | 32.29% |
2016 | 5.64 Million CAD | 23.22% |
2015 | 4.57 Million CAD | 0.0% |
2014 | - CAD | -100.0% |
2013 | 577.62 Thousand CAD | 14.52% |
2012 | 504.4 Thousand CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | -100.0% |
2009 | 17.01 Thousand CAD | -58.36% |
2008 | 40.84 Thousand CAD | -91.42% |
2007 | 476.06 Thousand CAD | -10.43% |
2006 | 531.52 Thousand CAD | 3.88% |
2005 | 511.68 Thousand CAD | -56.8% |
2004 | 1.18 Million CAD | 126.04% |
2003 | 524.06 Thousand CAD | -7.27% |
2002 | 565.13 Thousand CAD | 75.31% |
2001 | 322.36 Thousand CAD | -16.3% |
2000 | 385.15 Thousand CAD | 0.0% |
1999 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 60.06 Million USD | -1.31% |
2024 Q2 | 59.6 Million USD | -1.24% |
2024 Q3 | 58.93 Million USD | -1.25% |
2023 Q2 | 75.57 Million USD | 432.87% |
2023 Q1 | 14.18 Million USD | 29.79% |
2023 Q3 | 75.63 Million USD | 0.08% |
2023 Q4 | 60.82 Million USD | -19.58% |
2023 FY | 60.82 Million USD | 456.61% |
2022 FY | 10.92 Million USD | -36.03% |
2022 Q1 | 17.76 Million USD | 4.02% |
2022 Q4 | 10.92 Million USD | -32.86% |
2022 Q2 | 16.16 Million USD | -9.0% |
2022 Q3 | 16.27 Million USD | 0.66% |
2021 Q1 | 18.16 Million USD | 9.81% |
2021 FY | 17.08 Million USD | 3.28% |
2021 Q4 | 17.08 Million USD | -4.9% |
2021 Q3 | 17.96 Million USD | -16.79% |
2021 Q2 | 21.58 Million USD | 18.85% |
2020 Q4 | 16.53 Million CAD | 7.27% |
2020 FY | 16.53 Million CAD | 28.43% |
2020 Q3 | 15.41 Million CAD | 10.02% |
2020 Q1 | 15.23 Million CAD | 18.34% |
2020 Q2 | 14.01 Million CAD | -8.05% |
2019 Q2 | 12.84 Million CAD | 51.78% |
2019 Q3 | 12.8 Million CAD | -0.29% |
2019 Q4 | 12.87 Million CAD | 0.54% |
2019 FY | 12.87 Million CAD | 45.43% |
2019 Q1 | 8.46 Million CAD | -4.42% |
2018 Q3 | 8.11 Million CAD | -0.01% |
2018 Q1 | 8.05 Million CAD | 7.87% |
2018 FY | 8.85 Million CAD | 18.65% |
2018 Q2 | 8.11 Million CAD | 0.78% |
2018 Q4 | 8.85 Million CAD | 9.15% |
2017 Q1 | 8.16 Million CAD | 44.73% |
2017 Q4 | 7.46 Million CAD | -6.04% |
2017 Q3 | 7.94 Million CAD | 8.75% |
2017 Q2 | 7.3 Million CAD | -10.54% |
2017 FY | 7.46 Million CAD | 32.29% |
2016 Q1 | 7.96 Million CAD | 73.94% |
2016 Q3 | 5.52 Million CAD | -33.48% |
2016 Q4 | 5.64 Million CAD | 2.11% |
2016 FY | 5.64 Million CAD | 23.22% |
2016 Q2 | 8.3 Million CAD | 4.3% |
2015 Q3 | 5.24 Million CAD | -18.62% |
2015 Q4 | 4.57 Million CAD | -12.74% |
2015 Q2 | 6.44 Million CAD | 42.61% |
2015 FY | 4.57 Million CAD | 0.0% |
2015 Q1 | 4.52 Million CAD | 0.0% |
2014 Q2 | 405.32 Thousand CAD | -10.38% |
2014 Q3 | 755.36 Thousand CAD | 86.36% |
2014 Q4 | - CAD | -100.0% |
2014 Q1 | 452.24 Thousand CAD | -21.71% |
2014 FY | - CAD | -100.0% |
2013 FY | 577.62 Thousand CAD | 14.52% |
2013 Q1 | 503.27 Thousand CAD | -0.22% |
2013 Q4 | 577.62 Thousand CAD | 19.3% |
2013 Q3 | 484.17 Thousand CAD | -2.46% |
2013 Q2 | 496.38 Thousand CAD | -1.37% |
2012 Q4 | 504.4 Thousand CAD | -30.17% |
2012 FY | 504.4 Thousand CAD | 0.0% |
2012 Q2 | 732.49 Thousand CAD | 64.62% |
2012 Q1 | 444.95 Thousand CAD | 0.0% |
2012 Q3 | 722.38 Thousand CAD | -1.38% |
2011 FY | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q1 | 8959.03 CAD | -34.72% |
2010 FY | - CAD | -100.0% |
2010 Q2 | 3956.25 CAD | -55.84% |
2009 Q2 | 20.95 Thousand CAD | -20.09% |
2009 Q3 | 17.01 Thousand CAD | -18.84% |
2009 Q1 | 26.22 Thousand CAD | -23.31% |
2009 Q4 | 13.72 Thousand CAD | -19.32% |
2009 FY | 17.01 Thousand CAD | -58.36% |
2008 Q4 | 34.19 Thousand CAD | -16.28% |
2008 Q1 | 383.69 Thousand CAD | -10.95% |
2008 Q3 | 40.84 Thousand CAD | -87.77% |
2008 Q2 | 333.98 Thousand CAD | -12.96% |
2008 FY | 40.84 Thousand CAD | -91.42% |
2007 Q2 | 780.36 Thousand CAD | 60.79% |
2007 Q1 | 485.33 Thousand CAD | -1.7% |
2007 Q4 | 430.87 Thousand CAD | -9.49% |
2007 FY | 476.06 Thousand CAD | -10.43% |
2007 Q3 | 476.06 Thousand CAD | -38.99% |
2006 Q1 | 502.63 Thousand CAD | -6.53% |
2006 Q4 | 493.74 Thousand CAD | -7.11% |
2006 FY | 531.52 Thousand CAD | 3.88% |
2006 Q2 | 550.29 Thousand CAD | 9.48% |
2006 Q3 | 531.52 Thousand CAD | -3.41% |
2005 FY | 511.68 Thousand CAD | -56.8% |
2005 Q1 | 1.26 Million CAD | 1.05% |
2005 Q2 | 1.31 Million CAD | 4.11% |
2005 Q4 | 537.75 Thousand CAD | 5.09% |
2005 Q3 | 511.68 Thousand CAD | -61.03% |
2004 Q4 | 1.24 Million CAD | 5.35% |
2004 Q1 | 585.41 Thousand CAD | 5.7% |
2004 FY | 1.18 Million CAD | 126.04% |
2004 Q2 | 1.26 Million CAD | 116.56% |
2004 Q3 | 1.18 Million CAD | -6.56% |
2003 Q3 | 524.06 Thousand CAD | -5.06% |
2003 Q2 | 551.98 Thousand CAD | 2.5% |
2003 FY | 524.06 Thousand CAD | -7.27% |
2003 Q1 | 538.53 Thousand CAD | -2.71% |
2003 Q4 | 553.86 Thousand CAD | 5.69% |
2002 Q1 | 313.44 Thousand CAD | -11.13% |
2002 FY | 565.13 Thousand CAD | 75.31% |
2002 Q4 | 553.55 Thousand CAD | -2.05% |
2002 Q3 | 565.13 Thousand CAD | 102.91% |
2002 Q2 | 278.51 Thousand CAD | -11.14% |
2001 FY | 322.36 Thousand CAD | -16.3% |
2001 Q4 | 352.7 Thousand CAD | 0.0% |
2000 FY | 385.15 Thousand CAD | 0.0% |
1999 FY | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 36.1 Million USD | -68.47% |
BrainsWay Ltd. | 239 Thousand USD | -25348.156% |
Cerus Corporation | 59.79 Million USD | -1.714% |
Envoy Medical, Inc. | 404 Thousand USD | -14954.726% |
electroCore, Inc. | 537 Thousand USD | -11226.088% |
Helius Medical Technologies, Inc. | 12 Thousand USD | -506742.433% |
IceCure Medical Ltd | 376 Thousand USD | -16075.822% |
Inogen, Inc. | 18.27 Million USD | -232.901% |
OrthoPediatrics Corp. | 13.45 Million USD | -351.899% |
Lucid Diagnostics Inc. | 199 Thousand USD | -30463.363% |
Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -16621.77% |
MaxCyte, Inc. | 17.96 Million USD | -238.478% |
NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -109915.722% |
Nexalin Technology, Inc. | - USD | -Infinity% |
Orthofix Medical Inc. | 93.1 Million USD | 34.676% |
PAVmed Inc | 2.96 Million USD | -1954.767% |
Rapid Micro Biosystems, Inc. | 6.21 Million USD | -878.775% |
RxSight, Inc. | 1.21 Million USD | -4922.386% |
Sight Sciences, Inc. | 31.7 Million USD | -91.816% |
SI-BONE, Inc. | 36.06 Million USD | -68.643% |
TELA Bio, Inc. | 40.51 Million USD | -50.12% |
Treace Medical Concepts, Inc. | 53 Million USD | -14.739% |
Vivos Therapeutics, Inc. | 1.52 Million USD | -3898.757% |
Acutus Medical, Inc. | 32.65 Million USD | -86.259% |
Talis Biomedical Corporation | 16.78 Million USD | -262.332% |
Spectral AI, Inc. | - USD | -Infinity% |
Nano-X Imaging Ltd. | 4.04 Million USD | -1403.612% |
CVRx, Inc. | 30.38 Million USD | -100.188% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
PetVivo Holdings, Inc. | 1.01 Million USD | -5880.853% |
Bioventus Inc. | 366.99 Million USD | 83.427% |
Venus Concept Inc. | 70.79 Million USD | 14.082% |
TriSalus Life Sciences, Inc. | 1.24 Million USD | -4789.155% |
LivaNova PLC | 568.54 Million USD | 89.302% |
908 Devices Inc. | 3.92 Million USD | -1448.004% |
Alphatec Holdings, Inc. | 511.03 Million USD | 88.098% |
Nemaura Medical Inc. | 3.08 Million USD | -1869.818% |
NeuroPace, Inc. | 56.95 Million USD | -6.79% |
LENSAR, Inc. | 1.75 Million USD | -3375.491% |
Apyx Medical Corporation | 33.18 Million USD | -83.279% |
Cutera, Inc. | 418.69 Million USD | 85.474% |
STRATA Skin Sciences, Inc. | 15.04 Million USD | -304.288% |
BioSig Technologies, Inc. | 103 Thousand USD | -58949.604% |
Anika Therapeutics, Inc. | 26.9 Million USD | -126.067% |
ClearPoint Neuro, Inc. | 9.94 Million USD | -511.329% |
Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 95.904% |
Axonics, Inc. | 25.84 Million USD | -135.376% |
Outset Medical, Inc. | 134.59 Million USD | 54.812% |
IRIDEX Corporation | 1.75 Million USD | -3373.506% |
PROCEPT BioRobotics Corporation | 51.33 Million USD | -18.47% |
IRadimed Corporation | 1.61 Million USD | -3665.825% |
Tivic Health Systems, Inc. | 176 Thousand USD | -34457.439% |
INVO Bioscience, Inc. | 6.77 Million USD | -797.584% |
Telesis Bio, Inc. | 5.26 Million USD | -1054.319% |
Viemed Healthcare, Inc. | 5.97 Million USD | -918.558% |
Varex Imaging Corporation | 464.2 Million USD | 86.898% |
Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -10243.723% |
Pulmonx Corporation | 35.08 Million USD | -73.334% |
Dynatronics Corporation | 3.25 Million USD | -1766.549% |
Modular Medical, Inc. | 817 Thousand USD | -7344.442% |
ReShape Lifesciences Inc. | 151 Thousand USD | -40178.869% |
Semler Scientific, Inc. | 70 Thousand USD | -86787.274% |
InMode Ltd. | 6.61 Million USD | -819.72% |
Bruker Corporation | 1.14 Billion USD | 94.686% |
Cytosorbents Corporation | 2.54 Million USD | -2291.841% |
DexCom, Inc. | 2.57 Billion USD | 97.636% |
Align Technology, Inc. | 96.96 Million USD | 37.277% |
Viveve Medical, Inc. | 5.12 Million USD | -1086.985% |
ZimVie Inc. | 508.79 Million USD | 88.046% |
Movano Inc. | 15.00 USD | -405473846.667% |
Cytek Biosciences, Inc. | 18.12 Million USD | -235.565% |
Nexalin Technology, Inc. | - USD | -Infinity% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 398.6 Million USD | 84.742% |
Profound Medical Corp. | 4.97 Million USD | -1122.678% |
Insulet Corporation | 1.36 Billion USD | 95.549% |
enVVeno Medical Corporation | 1.06 Million USD | -5616.268% |
Surmodics, Inc. | 29.4 Million USD | -106.839% |
iCAD, Inc. | 273 Thousand USD | -22178.788% |
Nuwellis, Inc. | 221 Thousand USD | -27420.856% |
Biotricity, Inc. | 10.85 Million USD | -460.262% |
iRhythm Technologies, Inc. | 34.95 Million USD | -74.023% |
Aethlon Medical, Inc. | 649.75 Thousand USD | -9260.677% |
InspireMD, Inc. | 1.03 Million USD | -5759.45% |
PAVmed Inc. | 2.96 Million USD | -1954.767% |
BIOLASE, Inc. | 13.98 Million USD | -334.902% |
Beyond Air, Inc. | 14.72 Million USD | -313.159% |
FONAR Corporation | 37.92 Million USD | -60.353% |
AxoGen, Inc. | 46.6 Million USD | -30.509% |
Vivani Medical, Inc. | 19.31 Million USD | -214.923% |
Tactile Systems Technology, Inc. | 44.61 Million USD | -36.333% |
Inari Medical, Inc. | 30.35 Million USD | -100.366% |
UFP Technologies, Inc. | 28 Million USD | -117.218% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 434.04 Thousand USD | -13912.624% |
Tenon Medical, Inc. | 428 Thousand USD | -14110.536% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | -5969.969% |
Co-Diagnostics, Inc. | 2.15 Million USD | -2726.023% |
AdaptHealth Corp. | 2.09 Billion USD | 97.096% |
Sintx Technologies, Inc. | 3.68 Million USD | -1549.609% |
NanoVibronix, Inc. | - USD | -Infinity% |
Quanterix Corporation | 37.22 Million USD | -63.397% |
Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -10243.723% |
Sensus Healthcare, Inc. | 596 Thousand USD | -10104.881% |
Pacific Biosciences of California, Inc. | 892.24 Million USD | 93.183% |
TransMedics Group, Inc. | 506.2 Million USD | 87.985% |
ReWalk Robotics Ltd. | 607 Thousand USD | -9919.949% |
NeuroMetrix, Inc. | 92.48 Thousand USD | -65663.196% |
Hyperfine, Inc. | 64 Thousand USD | -94932.956% |
Establishment Labs Holdings Inc. | 188.73 Million USD | 67.775% |
Biomerica, Inc. | 459 Thousand USD | -13150.783% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -13431.344% |
Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -31913.291% |
Silk Road Medical, Inc | 75.62 Million USD | 19.576% |